Provided by Tiger Fintech (Singapore) Pte. Ltd.

Veracyte

28.44
-1.6900-5.61%
Volume:445.63K
Turnover:12.67M
Market Cap:2.22B
PE:91.74
High:29.40
Open:28.53
Low:28.00
Close:30.13
Loading ...

If You Invested $1000 in Veracyte a Decade Ago, This is How Much It'd Be Worth Now

Zacks
·
11 Dec 2024

5 Medical Device Stocks That Survived the 2024 Market Volatility

Zacks
·
11 Dec 2024

Top Analyst Reports for Alphabet, Oracle & Merck

Zacks
·
11 Dec 2024

BRIEF-Veracyte’S Decipher Prostate Test Is Now The Only Gene Expression Test Recommended In Nccn® Prostate Cancer Guidelines

Reuters
·
06 Dec 2024

Veracyte’s Decipher Prostate Test Is NOW the Only Gene Expression Test Recommended in Nccn® Prostate Cancer Guidelines

THOMSON REUTERS
·
06 Dec 2024

Goldman Sachs Downgrades Veracyte to Neutral From Buy, Trims Price Target to $37 From $38

MT Newswires Live
·
05 Dec 2024

Veracyte downgraded to Neutral from Buy at Goldman Sachs

TIPRANKS
·
05 Dec 2024

Veracyte Is Maintained at Underweight by Morgan Stanley

Dow Jones
·
18 Nov 2024

Morgan Stanley Lifts Price Target on Veracyte to $28 From $26, Keeps Underweight Rating

MT Newswires Live
·
18 Nov 2024

Sell Rating on Veracyte: Strong Performance Overshadowed by Limited Immediate Upside

TIPRANKS
·
18 Nov 2024

Top Calls on Wall Street: Starbucks, United Airlines, Delta Air Lines, Twilio, Morgan Stanley and More

Tiger Newspress
·
15 Nov 2024

Wolfe Research Initiates Veracyte at Outperform With $50 Price Target

MT Newswires Live
·
15 Nov 2024

Veracyte initiated with an Outperform at Wolfe Research

TIPRANKS
·
15 Nov 2024

Veracyte, Inc. Just Recorded A 296% EPS Beat: Here's What Analysts Are Forecasting Next

Simply Wall St.
·
09 Nov 2024

Veracyte price target raised to $44 from $40 at Scotiabank

TIPRANKS
·
08 Nov 2024

Stock Track | Veracyte Soars 8% After Impressive Q3 Results, Raised Guidance Fuel Growth Optimism

Stock Track
·
08 Nov 2024

Veracyte Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
08 Nov 2024

Stock Track | Veracyte Surges on Strong Q3 Results, Bullish Growth Outlook

Stock Track
·
08 Nov 2024

UBS Adjusts Price Target on Veracyte to $46 From $43, Maintains Buy Rating

MT Newswires Live
·
08 Nov 2024

Veracyte Inc (VCYT) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Outlook

GuruFocus.com
·
07 Nov 2024